BackTitan Pharmaceuticals (de) Overview

Titan Pharmaceuticals (de) Operating Income

Operating Income for TTNP.

Quarterly Operating Income

$-777000.00
↑ 3.05% YoY

As of Sep 30, 2025

Annual Operating Income (TTM)

$-2634000.00
↓ 54.76% YoY

Trailing 12 months ending Sep 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin